Dr. Adediran Anthonia Oluwatosin is a Senior Lecturer in the Department of Real Estate, Faculty of Built Environment, Universiti Malaya, with over 13 years of academic experience. She holds a PhD in Real Estate from Universiti Teknologi Malaysia, focusing on housing finance; a Master’s in Real Estate Development and Investment from the University of Greenwich, UK; and an HND in Estate Management from Yaba College of Technology, Nigeria. She also completed specialized training in Data Science in Real Estate at the MIT School of Architecture and Planning, USA. Before joining UM, she served as an Adjunct Assistant Professor at the Federal University of Uberlândia, Brazil and a lecturer at the Federal Polytechnic, Ado-Ekiti. Her research interests include housing finance, housing affordability, green finance, PropTech, data analytics, energy efficiency, and sustainable real estate development. She has published extensively on machine learning applications in renewable energy, climate change, and housing, with several papers indexed in Scopus and Web of Science. Dr. Adediran applies advanced econometric modeling, statistical analysis, and big data analytics in her work. She supervises postgraduate students, teaches real estate finance and analytics-related courses, and contributes to program development and faculty committees.

Professor Dr Hasniza Zaman Huri, currently the Deputy Vice Chancellor of Academic and International at Universiti Malaya, a reputable university ranked 58th in the QS World University Rankings. She is an accomplished academic pharmacist and, prior to her current tenure, was the founding Dean of the Faculty of Pharmacy at Universiti Malaya. Under her leadership, the faculty has achieved numerous accolades, including being a founding member of the Global Alliance for the Development of Pharmaceutical Science (GADPS), an alliance to spearhead the excellent teaching & learning and research of pharmacy/pharmaceutical sciences school around the globe, the top KPI achiever for academic centre in 2023, top faculty for graduate employability and for the first time, top 100 (#72) for Pharmacy subject ranking in the QS World University Rankings 2024. Professor Dr Hasniza was also appointed as the GADPS General Assembly Representative.  As a leading clinical scientist in clinical pharmacy, precision medicine and targeted therapy, she was honoured with the World Class Professor Programme by the Indonesian Government in 2022, among 78 professors globally. Professor Dr Hasniza's research expertise focuses on targeted therapy, drug utilisation and precision medicine, especially in metabolic diseases. She has been invited by various countries such as the United Kingdom, Uzbekistan, Turkey, China, India, Taiwan, and Indonesia as a Keynote or Plenary Speaker at conferences. She has published over 110 publications indexed in the Web of Science (WoS). Professor Dr Hasniza is also an expert in the clinical trial industry and is recognized for her exemplary leadership. She was the Manager and later Director of the Clinical Investigation Centre (CIC) at the University Malaya Medical Centre (UMMC). During her tenure, CIC UMMC gained a world-class reputation, winning multiple distinctions, including being the first Strategic Alliance Site for Parexel Inc. in Malaysia, Pfizer’s INSPIRE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) Site in Malaysia, Best Clinical Trial Service Provider in Asia, Top-10 IQVIA Prime Sites in the world and many more. She was awarded Best Academic Administrator for Non-Academic Centre in 2015 by Universiti Malaya and recently, in 2024, was awarded the MPS Outstanding Leadership Award by the Malaysian Pharmacists Society (MPS), an excellence award due to her outstanding performance and exceptional achievement in pharmacy practice in Malaysia. She is also the Honorary Visiting Consultant at CIC and a member of the Drug Control Authority (DCA) Ministry of Health, Malaysia. Professor Dr Hasniza has been awarded Fellow of Malaysian Pharmacists Society (FMPS), beginning January 1, 2026 a prestigious recognition by the national professional association for pharmacists in Malaysia for distinguished leadership and sustained contributions to the development of pharmacy practice, education, and professional advancement within the profession. She was also appointed as the Key Opinion Leader (KOL) to shape the policy and governance of clinical trials by Benchmarking of Academic Research Organisations, a Key Driver of Clinical Research in ASEAN - A Data Envelopment Analysis Approach, based in Japan.    

Sadia Rahman received her doctoral degree in International Relations from National Chung Hsing University, Taiwan in 2022. She pursued her MA from Presidency University and BA from Calcutta University, India. Before joining Universiti Malaya Rahman worked as an Assistant Professor at Atatürk University, Türkiye in 2023. Presently, she is a lecturer at the Department of International and Strategic Studies, with her research interests primarily focusing on International Relations, Global Governance, Human Rights, China Studies (China's domestic/ethnic policies and foreign policy), Cross-Strait Relations (Regional Security Issues) and South Asia. Her academic achievements include receiving prestigious scholarships such as the MOFA Taiwan fellowship and MOE doctoral scholarship from the ROC government. She obtained a grant from the Taiwan Foundation for Democracy for her project on human rights, further highlighting her dedication to impactful research. In 2021, Rahman was awarded the Outstanding Student Award by the ROC government for her exceptional academic accomplishments. In addition to her academic pursuits, Rahman serves as the Associate Editor of the Asian Journal of Interdisciplinary Research, showcasing her active involvement in the scholarly community. She has also been a participant in the XUAR workshop, a European Union funded (EU) project, including presenting her work at several international academic conferences.